A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720

Clinical trial NCT01578330 · COMPLETED

Trial details

NCT number: NCT01578330
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Relapsing-Remitting

Start date: 2012-10-01
Primary completion: 2015-04-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.